An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis
Recruiting
Observational Study
Ulcerative Colitis (UC)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 0 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 553 (estimated)
- Sponsor
- Pfizer · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A study to assess the safety and effectiveness of Velsipity Tablets 2 mg during long-term treatment (up to a maximum of 52 weeks) in patients with ulcerative colitis under actual medical practice.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Patients must meet all of the following inclusion criteria to be eligible for inclusion in the study:
1. Patients with moderate to severe ulcerative colitis for whom treatment with this drug was started for the first time after the contract date for this study. Patients who have participated in a c…
Contacts